Abstract

Progressive cerebral deposition of amyloid beta occurs in Alzheimeŕs disease and during the aging of certain mammals (human, monkey, dog, bear, cow, cat) but not others (rat, mouse). It is possibly due to different amino acid sequences at positions 5, 10 and 13. To address this issue, we performed series of 100 ns long trajectories (each trajectory was run twice with different initial velocity distribution) on amyloid beta (1–42) with the human and rat amino acid sequence in three different environments: water with only counter ions, water with NaCl at a concentration of 0.15 M as a model of intracellular Na+ concentration at steady state, and water with NaCl at a concentration of 0.30 M as a model of intracellular Na+ concentration under stimulated conditions. We analyzed secondary structure stability, internal hydrogen bonds, and residual fluctuation. It was observed that the change in ionic strength affects the stability of internal hydrogen bonds. Increasing the ionic strength increases atomic fluctuation in the hydrophobic core of the human amyloid, and decreases the atomic fluctuation in the case of rat amyloid. The secondary structure analyses show a stable α-helix part between residues 10 and 20. However, C-terminus of investigated amyloids is much more flexible showing no stable secondary structure elements. Increasing ionic strength of the solvent leads to decreasing stability of the secondary structural elements. The difference in conformational behavior of the three amino acids at position 5, 10 and 13 for human and rat amyloids significantly changes the conformational behavior of the whole peptide.

Highlights

  • Alzheimer’s disease (AD) is a neurodegenerative disorder that affects more than 30 million people worldwide

  • In this study we aimed to elucidate the effect of ionic strength on the conformational behavior of amyloid beta peptides with human and rat amino acid sequences using molecular dynamics simulations

  • We found the fold between residues ASN27 and ILE32 in all simulations of human amyloid peptide, which is in agreement with experimental results

Read more

Summary

Introduction

Alzheimer’s disease (AD) is a neurodegenerative disorder that affects more than 30 million people worldwide. AD patients experience a progressive decline in their cognitive functions and loss of short term memory with aging [1]. The brain regions most commonly affected in AD are the hippocampus and entorhinal cortex, both of which are involved in short-term memory and learning processes [2]. Histopathological examination of AD brain slices reveals amyloid-beta peptide (Ab) deposits. The extracellular plaques mainly contain aggregates of amyloid-beta (Ab) peptides. More recent research suggests that soluble monomeric or oligomeric amyloid is first deposited in the neuron and later in the extra-cellular space and that this intra-cellular accumulation of amyloid is one of the first neurodegenerative alterations in AD brains [3]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call